VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IART
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IARTIntegra LifeSciences Holdings Corporation
$17.46$1.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIARTQuarterly Financials

Integra LifeSciences Holdings Corporation (IART) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Integra LifeSciences Holdings Corporation (IART) quarterly income statement — complete revenue, gross profit & net income history

IART Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue391.92M434.93M402.06M415.61M382.65M442.65M380.83M418.18M368.87M397.04M382.42M381.27M380.85M398.02M385.19M397.81M376.64M405.52M386.86M389.99M
Revenue Growth %2.42%-1.74%5.57%-0.61%3.74%11.49%-0.41%9.68%-3.14%-0.25%-0.72%-4.16%1.12%-1.85%-0.43%2.01%4.6%4.34%4.49%50.77%
Cost of Goods Sold0219.56M175.95M206.27M188.22M193.57M180.6M192.26M162.04M170.55M164.08M174.24M147.97M147.94M148.44M148.4M142.57M156.25M144.47M151.27M
COGS % of Revenue-50.48%43.76%49.63%49.19%43.73%47.42%45.98%43.93%42.95%42.9%45.7%38.85%37.17%38.54%37.3%37.85%38.53%37.34%38.79%
Gross Profit0215.36M226.11M209.33M194.43M249.07M200.24M225.92M206.83M226.49M218.34M207.03M232.87M250.09M236.75M249.41M234.07M249.27M242.39M238.72M
Gross Margin %-49.52%56.24%50.37%50.81%56.27%52.58%54.02%56.07%57.05%57.1%54.3%61.15%62.83%61.46%62.7%62.15%61.47%62.66%61.21%
Gross Profit Growth %-100%-13.53%12.92%-7.34%-6%9.97%-8.29%9.12%-11.18%-9.43%-7.77%-16.99%-0.51%0.33%-2.33%4.48%9.25%3.19%2.96%55.84%
Operating Expenses201.74M-340.84M185.82M722.01M209.93M213.44M208.39M228.95M202.87M190.45M191.75M194.52M196.49M182.25M171.7M189.54M187.91M191.05M185.95M186.87M
OpEx % of Revenue51.47%-78.37%46.22%173.72%54.86%48.22%54.72%54.75%55%47.97%50.14%51.02%51.59%45.79%44.57%47.65%49.89%47.11%48.07%47.92%
Selling, General & Admin178.24M169.27M169.05M179.89M181.5M178.52M177.19M195.47M165.8M163.13M161.95M164.91M166.66M151.92M143.82M160.65M159.93M162.25M156.01M162.55M
SG&A % of Revenue45.48%38.92%42.04%43.28%47.43%40.33%46.53%46.74%44.95%41.09%42.35%43.25%43.76%38.17%37.34%40.38%42.46%40.01%40.33%41.68%
Research & Development23.5M24.79M22.46M27M24.73M31.21M27.43M29.77M26.96M24.28M26.6M26.59M26.72M26.78M24.74M25.59M24.09M24.73M25.83M20.12M
R&D % of Revenue6%5.7%5.59%6.5%6.46%7.05%7.2%7.12%7.31%6.12%6.95%6.97%7.02%6.73%6.42%6.43%6.39%6.1%6.68%5.16%
Other Operating Expenses0-1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income11.47M556.2M40.29M-512.67M-15.5M35.63M-8.15M-3.03M3.96M36.05M26.59M12.5M36.38M67.84M65.05M59.87M46.16M58.22M56.44M51.85M
Operating Margin %2.93%127.88%10.02%-123.36%-4.05%8.05%-2.14%-0.72%1.07%9.08%6.95%3.28%9.55%17.04%16.89%15.05%12.26%14.36%14.59%13.3%
Operating Income Growth %174.01%1461.17%594.37%-16825.52%-490.94%-1.17%-130.65%-124.22%-89.1%-46.86%-59.12%-79.11%-21.19%16.52%15.26%15.45%50.3%10.6%-1.92%268.28%
EBITDA11.47M594.2M78.45M-474.98M21.69M73.12M27.81M33.75M34.53M67.03M57.15M43.33M68.78M97.33M96.16M90.89M75.87M89.65M87.13M82.61M
EBITDA Margin %2.93%136.62%19.51%-114.29%5.67%16.52%7.3%8.07%9.36%16.88%14.94%11.36%18.06%24.45%24.96%22.85%20.14%22.11%22.52%21.18%
EBITDA Growth %-47.12%712.65%182.09%-1507.44%-37.18%9.08%-51.34%-22.11%-49.8%-31.13%-40.57%-52.33%-9.34%8.57%10.36%10.02%23.47%13.74%-1.62%88.81%
D&A (Non-Cash Add-back)038.01M38.16M37.69M37.19M37.49M35.96M36.78M30.57M30.98M30.56M30.83M32.4M29.49M31.11M31.02M29.71M31.43M30.69M30.76M
EBIT027.98M15.9M-509.91M-11.22M41.52M-989K3.47M8.39M42.61M31.67M16.29M41.88M74.63M71.61M63.81M45.76M58.46M57.55M52.15M
Net Interest Income0-19.31M-17.74M-16.33M-18.45M-14.09M-14.32M-13.59M-8.58M-9.2M-8.46M-8.53M-7.99M-7.58M-9.54M-10.27M-10.28M-10.69M-10.41M-11.38M
Interest Income4.11M4.36M4.98M4.71M1.79M4.89M5.05M5.06M5.04M4.55M4.61M3.94M4.11M5.31M3.26M1.97M1.38M1.44M1.79M1.76M
Interest Expense-22.46M23.67M22.73M21.04M20.24M18.98M19.37M18.65M13.62M13.75M13.06M12.46M12.1M12.89M12.81M12.24M11.65M12.13M12.19M13.15M
Other Income/Expense-13.88M-551.89M-47.12M-18.28M-14.54M-13.09M-12.21M-12.16M-9.19M-7.19M-7.98M-8.68M-6.6M-3.63M-6.25M-8.29M-6.85M-6.44M-5.65M-7.03M
Pretax Income-2.41M4.31M-6.82M-530.95M-30.04M22.54M-20.36M-15.19M-5.23M28.86M18.61M3.82M29.78M64.21M58.8M51.58M39.31M51.79M50.79M44.82M
Pretax Margin %-0.61%0.99%-1.7%-127.75%-7.85%5.09%-5.35%-3.63%-1.42%7.27%4.87%1%7.82%16.13%15.26%12.96%10.44%12.77%13.13%11.49%
Income Tax2.21M6.01M-1.42M-46.88M-4.74M3.11M-9.67M-2.78M-1.95M9.02M-888K-360K5.55M11.26M8.88M6.79M6.41M6.4M7.56M9.76M
Effective Tax Rate %-91.66%139.54%20.81%8.83%15.79%13.78%47.48%18.33%37.27%31.27%-4.77%-9.41%18.64%17.54%15.1%13.16%16.31%12.36%14.88%21.77%
Net Income-4.62M-1.7M-5.4M-484.07M-25.29M19.43M-10.7M-12.4M-3.28M19.83M19.5M4.18M24.23M52.95M49.91M44.79M32.9M45.38M43.23M35.07M
Net Margin %-1.18%-0.39%-1.34%-116.47%-6.61%4.39%-2.81%-2.97%-0.89%5%5.1%1.1%6.36%13.3%12.96%11.26%8.74%11.19%11.17%8.99%
Net Income Growth %81.75%-108.77%49.47%-3803.18%-670.89%-2.01%-154.85%-396.41%-113.54%-62.54%-60.94%-90.66%-26.37%16.66%15.47%27.72%-27.52%-51.07%33.68%9603.52%
Net Income (Continuing)-4.62M-1.7M-5.4M-484.07M-25.29M19.43M-10.7M-12.4M-3.28M19.83M19.5M4.18M24.23M52.95M49.91M44.79M32.9M45.38M43.23M35.07M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.06-0.02-0.07-6.33-0.330.25-0.14-0.16-0.040.250.240.050.290.630.600.540.390.530.510.41
EPS Growth %81.82%-108.88%49.71%-3856.25%-681.99%0%-158.33%-410.08%-114.55%-60.32%-60%-90.44%-25.64%18.87%17.65%31.71%-26.42%-51.38%34.21%-
EPS (Basic)-0.06-0.02-0.07-6.33-0.330.25-0.14-0.16-0.040.250.240.050.300.630.600.540.390.540.510.41
Diluted Shares Outstanding76.95M76.75M76.75M76.46M76.46M77.01M76.45M77.41M77.73M78.33M79.81M81.15M82.32M83.65M83.4M83.62M84.28M85.78M85.45M85.34M
Basic Shares Outstanding76.95M76.75M76.75M76.46M76.46M77.01M76.45M77.41M77.73M78.33M79.69M80.97M81.87M83.65M83.04M83.17M83.63M84.7M84.75M84.69M
Dividend Payout Ratio--------------------